Fauci experienced COVID-19 rebound after taking one course of Paxlovid. After his symptoms returned with a vengeance, he took a second course, which experts believe could be triggering SARS-CoV-2 mutations and resistance. STORY AT-A-GLANCE The U.S. Centers for Disease Control and Prevention issued a warning about the potential for COVID-19 rebound after Paxlovid treatment Dr….
Fauci Likely to Birth His Own COVID Variant After Paxlovid
July 13, 2022
admin
BrightCorona viruscoronavirus mutationcoronavirus mutationsCOVIDCOVID-19healthHealth ConditionsHealth ViewpointsInfectious DiseasesPaxlovid
0 Comment
Will COVID-19 Vaccines Drive Mutated Variants?
Despite media reports suggesting unvaccinated people will drive mutations of SARS-CoV-2 (or the CCP virus, which causes COVID-19), actual research suggests that more dangerous mutations of the virus could come from the specific nature of the vaccines now being used around the world. Half of Americans have declined the vaccine. Only 49 percent of Americans more…
New CCP Virus Strain Spreads Fast in New York City
New research suggests that a new strain of the CCP virus—called B.1.526—is spreading quickly in New York City and features mutations associated with higher viral infectivity and greater resistance to antibodies—though experts caution more study is needed to verify the “fitness” of the mutant virus. Variants of the CCP (Chinese Communist Party) virus—commonly known as the…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta